Replies to post #102927 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

TW partner starting their lung cancer trial will not move a needle. They will not provide any upfront cash to ADXS, however, they pay for the trial. It's a non-event. Can you recall what happened to another investigator sponsored trial (OS Therapies for pediatric osteosarcoma) that started in 2018? What happened to an IST trial for H&N cancer that was supposed to start in 2019/H1? Those ISTs are just some decoy operations designed to stir a trading activity. Never materialize into something tangible. Never. It's not going to be different this time around.

But at least it is helping Ken get that 500K annual salary (minimum). Would be interesting to know how much 'additional bonus' he has got for the stellar performance in 2019.

[James salmon]

It may not be a big needle mover, but it’s still positive for something many thought was not going to happen.